Antoni Ribas - 23 Jan 2025 Form 4 Insider Report for Arcus Biosciences, Inc. (RCUS)

Role
Director
Signature
/s/ Carolyn Tang, Attorney-in-Fact
Issuer symbol
RCUS
Transactions as of
23 Jan 2025
Net transactions value
$0
Form type
4
Filing time
27 Jan 2025, 16:30:42 UTC
Previous filing
07 Jun 2024
Next filing
12 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RCUS Common Stock 30,350 23 Jan 2025 Direct
holding RCUS Common Stock 8,553 23 Jan 2025 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCUS Stock Option (right to buy) Award $0 +5,000 $0.000000 5,000 23 Jan 2025 Common Stock 5,000 $13.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is exercisable in 24 equal monthly installments after January 1, 2025, subject to the Reporting Person's continued service to the Company.